Provectus Pharmaceuticals News
Most Popular Provectus Pharmaceuticals Story
ALSO NOTED: Gates gives $280M to fight TB; Merck drug proves positive in Phase II;Merck KGaA exec eyes acquisitions;much more..
> Merck says that its mid-stage trial for the osteoporosis drug Odanacatib (formerly MK-0822) significantly boosted bone mineral density after 12 months. The trial tested four doses of the drug,... Read more...
Latest Headlines
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
